SRC and prostate cancer: c-Src is one of the most well-characterized protooncogenes and non-receptor protein tyrosine kinases, of which activation is a critical event in the tumorigenesis of a large number of human malignancies, including colon, gastric, breast, lung and prostate cancer [21–23].